Saluda Medical IncASX: SLD

CEO's Address to Shareholders

· Issued by Saluda Medical Inc

Filed with ASX · · 4 pages · English

Summary by 6ix AI

This filing is an address by Chief Executive Officer Mike Mathias to shareholders at Saluda Medical's annual meeting, detailing the company's achievements and future plans. The CEO highlighted significant revenue growth and advancements in their neuromodulation technology, particularly the FDA approval of a new product. He emphasized the company's commitment to expanding physician adoption and improving patient outcomes through innovative therapies.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Saluda Medical, Inc.(ASX:SLD, “Saluda” or the “Company”) will hold its Annual Meeting today at 11:30AM (AEDT). Attached is a copy of the address to be given by the Chief Executive Officer at the Annual Meeting. The above details are provided in accordance with rule 3.13.3 of the ASX Listing Rules. This announcement has been authorised for release by Saluda’s Disclosure Committee. For more informat

Saluda Medical Inc on 6ix

Earlier from Saluda Medical

All Saluda Medical news releases